CrystalGenomics Participates in US 'Biotech Showcase 2021'

[Asia Economy Reporter Oh Ju-yeon] CrystalGenomics announced on the 14th that it will present an overview of its research and development status at the 'Biotech Showcase 2021' held in San Francisco, USA.

This conference, held from January 11 to 15 next year via video conference, is organized by Demy-Colton and the EBD Group, inviting key executives and investors from pharmaceutical and biotech companies every year.

This year, more than 3,700 senior executives and about 1,000 investors from over 50 countries are expected to participate.

Over the past decade, it has mainly provided a networking conference for innovative biotech startup companies, offering opportunities for investment firms and management to meet in one place and create licensing-out opportunities.

CrystalGenomics will present clinical data on Ivaltinostat, a new drug candidate for cancer and anti-fibrosis treatment, targeting investors and multinational pharmaceutical companies.

Through one-on-one partnering meetings, they plan to discuss partnership consultations and joint research and development.

A CrystalGenomics official stated, "In January next year, we plan to introduce our innovative drug development pipeline and global clinical trials through the Biotech Showcase and JP Morgan Healthcare Conference and pursue strategic partnerships."

This content was produced with the assistance of AI translation services.